Search

Your search keyword '"Obesity -- Drug therapy -- Risk factors"' showing total 5 results
Start Over Descriptor "Obesity -- Drug therapy -- Risk factors" Topic drugs
5 results on '"Obesity -- Drug therapy -- Risk factors"'

2. Risk of Suicidal Ideation Lower With Semaglutide vs Other Obesity, T2D Drugs

Author

Ernst, Diana

Subjects
United States. National Institutes of Health, Drug therapy, Risk factors, Obesity -- Drug therapy -- Risk factors, Drugs, Suicidal behavior -- Drug therapy -- Risk factors, Semaglutide
Abstract

Semaglutide does not appear to increase the risk of suicidal ideation compared with non-glucagon-like peptide 1 receptor agonist (GLP-1RA) medications for obesity and diabetes, according to a retrospective cohort study [...]

Published
2024

3. Risk of Suicidal Ideation Lower With Semaglutide vs Other Obesity, T2D Drugs

Author

Ernst, Diana

Subjects
United States. National Institutes of Health, Drug therapy, Risk factors, Obesity -- Drug therapy -- Risk factors, Drugs, Suicidal behavior -- Drug therapy -- Risk factors, Semaglutide
Abstract

Semaglutide does not appear to increase the risk of suicidal ideation compared with non-glucagon-like peptide 1 receptor agonist (GLP-1RA) medications for obesity and diabetes, according to a retrospective cohort study [...]

Published
2024

4. Fighting obesity isn't as easy as taking drugs

Subjects
Obesity -- Drug therapy -- Risk factors, Drugs, Gastrointestinal system, Business, Computers and office automation industries, Telecommunications industry
Abstract

Byline: By The Nov. 27 editorial, 'Obesity drugs are saving lives. Make them available to all.,' omitted important information. These drugs can cause pancreatitis, bowel obstruction and gastroparesis (essentially paralysis [...]

Published
2023

5. New Clinical Data Demonstrate that QSYMIA(R), the Leading Once-Daily Oral Weight-Management Medication, Reduces Blood Pressure

Subjects
Blood pressure, Obesity -- Drug therapy -- Risk factors, Body weight, Drugs, Type 2 diabetes -- Drug therapy -- Risk factors, Atherosclerosis -- Risk factors -- Drug therapy, Hypertension -- Risk factors -- Drug therapy, Company business management, Banking, finance and accounting industries, Business
Abstract

CAMPBELL, Calif., Nov. 28, 2023 (GLOBE NEWSWIRE) -- VIVUS LLC, a biopharmaceutical company committed to the development and commercialization of innovative therapies that focus on advancing treatments for patients with [...]

Published
2023

Catalog

Books, media, physical & digital resources
See catalog results